Perioperative Aspirin Response in Patients Undergoing Vascular Surgery
|ClinicalTrials.gov Identifier: NCT03587324|
Recruitment Status : Completed
First Posted : July 16, 2018
Last Update Posted : July 18, 2018
|Condition or disease||Intervention/treatment||Phase|
|Vascular Surgery Patient With PAD / Carotid Stenosis||Drug: Whole blood aggregometry before and after vascular treatment (ASA/ Clopidogrel).||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||176 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Perioperative Risk Factors for the Development of Aspirin Low Response in Patients Undergoing Vascular Surgery.|
|Actual Study Start Date :||February 2013|
|Actual Primary Completion Date :||March 2015|
|Actual Study Completion Date :||March 2015|
Experimental: Experimental: aspirin, clopidogrel
Perioperative measurement of ASA and clopidogrel resistance in patients undergoing vascular treatment
Drug: Whole blood aggregometry before and after vascular treatment (ASA/ Clopidogrel).
To identify possible risk factors demographic data, concomitant medication, laboratory parameters, co-morbidities, severity of the condition and the type of procedure performed are documented.
Other Name: ASA (aspirin), Clopidogrel (Plavix)
- Number of Participants Who Were Responders or Low-Responders of Antiplatelet Therapy as a Result of Whole Blood Aggregometry Testing [ Time Frame: 2 years ]In patients treated with aspirin and clopidogrel aggregometry was performed and depending on the results the patients were either responder or low-responder of antiplatelet therapy.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03587324
|Department of vascular surgery, St. Josef Hospital, Ruhr University of Bochum|
|Bochum, NRW, Germany, 44791|